Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04937319 and Sitagliptin in Type 2 Diabetes
NCT01475461Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of nerigliatin in type 2 diabetes mellitus (T2DM), sponsored by Pfizer. Started Nov 2011; status: completed.
02
Drugs
nerigliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01475461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01475461.